Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals

被引：0
|
作者：
Maryam H. Alrashid
Ahmad Al-Serri
Salem H. Alshemmari
Philip Koshi
Suzanne A. Al-Bustan
机构：
[1] Kuwait University,Department of Biological Sciences, Faculty of Science
[2] Kuwait University,Department of Pathology, Faculty of Medicine
[3] Kuwait University,Department of Medicine, Faculty of Medicine
来源：
Molecular Diagnosis & Therapy | 2016年 / 20卷
关键词：
Warfarin; International Normalization Ratio; Single Nucleotide Polymorphism; Warfarin Dose; Warfarin Dose Requirement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：183 / 190
页数：7
相关论文
共 50 条
  • [41] Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin
    Barros Melo da Silveira, Maria Mariana
    Melo, Leiliandry de Ara
    Ferreira Gomes, Filipe Maia
    Barreto da Rocha Andrade, Leonardo Jose de Cupertino
    Serur, Isabela Paulino
    de Vasconcellos Piscoya, Isabelle Cecilia
    Gueiros, Raposo Marina
    do O, Kleyton Palmeira
    de Lima, Raul Emidio
    Eulalio Brasileiro, Victor Arthur
    Silva Vasconcelos, Luydson Richardson
    Sobral Filho, Dario Celestino
    APPLICATION OF CLINICAL GENETICS, 2019, 12 : 151 - 159
  • [42] Effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirement in Central China Han populations
    Li, Zhi-Jiang
    Liu, Xu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (11) : 2269 - 2274
  • [43] Prevalence of combinatorial genetic polymorphisms of CYP2C9 and VKORC1 in acute stroke patients: implications for warfarin management
    Supe, S.
    Poljakovic, Z.
    Bozina, N.
    Matijevic, V.
    Bazina, A.
    Miismas, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 167 - 167
  • [44] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    BLOOD, 2012, 120 (21)
  • [45] Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations
    Gin Gin Gan
    Maude E. Phipps
    Michael M. T. Lee
    Liang S. Lu
    Rajallectchumy Y. Subramaniam
    Ping C. Bee
    Sean H. Chang
    Annals of Hematology, 2011, 90 : 635 - 641
  • [46] Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations
    Gan, Gin Gin
    Phipps, Maude E.
    Lee, Michael M. T.
    Lu, Liang S.
    Subramaniam, Rajallectchumy Y.
    Bee, Ping C.
    Chang, Sean H.
    ANNALS OF HEMATOLOGY, 2011, 90 (06) : 635 - 641
  • [47] VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance
    Azzam, Hanan
    Elwakeel, Hossam
    Awad, Ibrahim
    El-Farahaty, Reham
    El-Gilany, Abdel-Hady
    El-Sharawy, Solafa
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (02) : 121 - 126
  • [48] Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 -: Rationale and perspectives
    Yin, Tong
    Miyata, Toshiyuki
    THROMBOSIS RESEARCH, 2007, 120 (01) : 1 - 10
  • [49] Polymorphism of the CYP2C9 and VKORC1 genes: a comment RESPONSE
    Colet, Christiane de Fatima
    JORNAL VASCULAR BRASILEIRO, 2021, 20
  • [50] Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population
    Hadjipanagi D.
    Chrysanthou S.
    Voskarides K.
    Deltas C.
    BMC Research Notes, 7 (1)
12345